HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preoperative cyclooxygenase-2 inhibitor treatment reduces the incidence of heterotopic ossification after hip arthroplasty: six-month follow-up.

AuthorsAsokumar Buvanendran, Jeffrey S Kroin, Richard A Berger
JournalAnesthesiology (Anesthesiology) Vol. 107 Issue 2 Pg. 358-9 (Aug 2007) ISSN: 0003-3022 [Print] United States
PMID17667588 (Publication Type: Letter, Randomized Controlled Trial, Comment)
Chemical References
  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Sulfones
  • rofecoxib
  • Dinoprostone
Topics
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Cyclooxygenase 2 Inhibitors (therapeutic use)
  • Dinoprostone (biosynthesis)
  • Drug Administration Schedule
  • Follow-Up Studies
  • Hip Joint (diagnostic imaging)
  • Humans
  • Incidence
  • Lactones (therapeutic use)
  • Ossification, Heterotopic (prevention & control)
  • Postoperative Complications (prevention & control)
  • Preoperative Care (methods)
  • Radiography
  • Sulfones (therapeutic use)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: